556 related articles for article (PubMed ID: 32297723)
1. COVID-2019: update on epidemiology, disease spread and management.
Sahu KK; Mishra AK; Lal A
Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
3. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
4. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Lu R; Zhao X; Li J; Niu P; Yang B; Wu H; Wang W; Song H; Huang B; Zhu N; Bi Y; Ma X; Zhan F; Wang L; Hu T; Zhou H; Hu Z; Zhou W; Zhao L; Chen J; Meng Y; Wang J; Lin Y; Yuan J; Xie Z; Ma J; Liu WJ; Wang D; Xu W; Holmes EC; Gao GF; Wu G; Chen W; Shi W; Tan W
Lancet; 2020 Feb; 395(10224):565-574. PubMed ID: 32007145
[TBL] [Abstract][Full Text] [Related]
5. The race against COVID-19.
Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
[No Abstract] [Full Text] [Related]
6. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Li H; Liu Z; Ge J
J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.
Khalaf K; Papp N; Chou JT; Hana D; Mackiewicz A; Kaczmarek M
Front Immunol; 2020; 11():570927. PubMed ID: 33123144
[TBL] [Abstract][Full Text] [Related]
8. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Gupta SP
Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
[TBL] [Abstract][Full Text] [Related]
9. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.
Abd Ellah NH; Gad SF; Muhammad K; E Batiha G; Hetta HF
Nanomedicine (Lond); 2020 Sep; 15(21):2085-2102. PubMed ID: 32723142
[TBL] [Abstract][Full Text] [Related]
11. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.
Yang Y; Peng F; Wang R; Yange M; Guan K; Jiang T; Xu G; Sun J; Chang C
J Autoimmun; 2020 May; 109():102434. PubMed ID: 32143990
[TBL] [Abstract][Full Text] [Related]
12. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.
Cao YC; Deng QX; Dai SX
Travel Med Infect Dis; 2020; 35():101647. PubMed ID: 32247927
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
Banerjee AK; Arora N
Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
[No Abstract] [Full Text] [Related]
14. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
[TBL] [Abstract][Full Text] [Related]
15. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
16. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
[No Abstract] [Full Text] [Related]
17. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
Jogalekar MP; Veerabathini A; Gangadaran P
Exp Biol Med (Maywood); 2020 Jun; 245(11):964-969. PubMed ID: 32306751
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: Time for precision epidemiology.
Koks S; Williams RW; Quinn J; Farzaneh F; Conran N; Tsai SJ; Awandare G; Goodman SR
Exp Biol Med (Maywood); 2020 Apr; 245(8):677-679. PubMed ID: 32301338
[No Abstract] [Full Text] [Related]
19. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
Giovane RA; Rezai S; Cleland E; Henderson CE
Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
[TBL] [Abstract][Full Text] [Related]
20. Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.
Fadaka AO; Sibuyi NRS; Adewale OB; Bakare OO; Akanbi MO; Klein A; Madiehe AM; Meyer M
J Int Med Res; 2020 Aug; 48(8):300060520949077. PubMed ID: 32842818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]